PROVIDER PROFILE · NPI 1083008601

Maja Lusk

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$848

Distinct drugs

Brand share

0.0%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

86.9

Quality

77.3

Cost

77.6

Improvement activities

40.0

Promoting interop.

90.0

Payment adjustment

0.50%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$582

Payment records

By payment type

Food and Beverage$582

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

Hospital

Hospital

CROSS-REFERENCE